tirzepatide and eye issues Semaglutide, Linked to Small Increase in Disorder Risk eye issues with tirzepatide Use

Research findings are preliminary and do not imply safety or efficacy.

We excluded patients with bariatric surgery history and required weight measurements during baseline (90 days pre-treatment), the first year post-treatment (year 1), and the second year post-treatment (year 2), yielding 34,143 semaglutide-treated and 16,034 tirzepatide-treated patients ( Figure S1 )

GLP-2 stimulates colonic growth via KGF, released by subepithelial myofibroblasts with GLP-2 receptors

Since dry mouth is not currently listed on the drug label as a common adverse reaction, it can be a surprise if youre taking semaglutide and experience low saliva or a sticky mouth

Additional Tips for Reducing Blood Clot Risks Women can also take steps to lower their risk of blood clots while using these medications: Avoid Smoking : Smoking increases the risk of blood clots, especially in combination with estrogen-containing contraceptives

Fasting protocols Researchers who practice intermittent fasting or other fasting protocols need to consider how tirzepatide appetite suppression interacts with their fasting window